Log in
Enquire now
‌

US Patent 9775844 Heterocyclic compounds and uses thereof

Patent 9775844 was granted and assigned to Infinity Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Infinity Pharmaceuticals
Infinity Pharmaceuticals
Current Assignee
Infinity Pharmaceuticals
Infinity Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9775844
Date of Patent
October 3, 2017
Patent Application Number
14661656
Date Filed
March 18, 2015
Patent Citations Received
‌
US Patent 12122833 Combination therapies of HDAC inhibitors and PD-1 inhibitors
0
Patent Primary Examiner
‌
Samira Jean-Louis
Patent abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9775844 Heterocyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.